drugset / Trial / NCT01595399

Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation

NCT01595399

Phase 4 Unknown 70 enrolled University of Manitoba
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to compare heart rate in infants who receive atropine as a part of their medication before intubation to those who do not. To be able to find out , we need to divided babies into 2 groups; group 1 : receives atropine + sedation + muscle relaxant group 2 : receives water or saline ( placebo group) + sedation + muscle relaxant Then we need to compare heart rate during intubation and duration of intubation between the 2 groups.

Timeline

Start
2012-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.02 mg/kg Intravenous

Indications

No indication recorded.